ROMANO, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.812
AS - Asia 1.140
EU - Europa 765
SA - Sud America 259
AF - Africa 243
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 11
Totale 6.255
Nazione #
US - Stati Uniti d'America 3.690
SG - Singapore 324
CN - Cina 283
BR - Brasile 184
HK - Hong Kong 156
IT - Italia 128
DE - Germania 109
FI - Finlandia 81
VN - Vietnam 79
GB - Regno Unito 48
PL - Polonia 45
SE - Svezia 38
FR - Francia 35
NL - Olanda 32
TR - Turchia 29
RU - Federazione Russa 28
IN - India 26
AR - Argentina 20
UA - Ucraina 19
AT - Austria 16
JP - Giappone 16
CA - Canada 15
IE - Irlanda 15
IQ - Iraq 14
MX - Messico 14
KG - Kirghizistan 13
CI - Costa d'Avorio 12
EC - Ecuador 12
GH - Ghana 12
MN - Mongolia 12
TW - Taiwan 12
ZA - Sudafrica 12
GN - Guinea 11
RO - Romania 11
BF - Burkina Faso 10
CV - Capo Verde 10
ES - Italia 10
HN - Honduras 10
HR - Croazia 10
ID - Indonesia 10
IS - Islanda 10
KE - Kenya 10
LV - Lettonia 10
TJ - Tagikistan 10
UZ - Uzbekistan 10
BW - Botswana 9
CZ - Repubblica Ceca 9
JO - Giordania 9
LB - Libano 9
TH - Thailandia 9
BB - Barbados 8
CH - Svizzera 8
CO - Colombia 8
DZ - Algeria 8
NI - Nicaragua 8
TZ - Tanzania 8
AL - Albania 7
BA - Bosnia-Erzegovina 7
BJ - Benin 7
EG - Egitto 7
GT - Guatemala 7
HU - Ungheria 7
IR - Iran 7
KH - Cambogia 7
LU - Lussemburgo 7
MA - Marocco 7
MR - Mauritania 7
MY - Malesia 7
NP - Nepal 7
PH - Filippine 7
PK - Pakistan 7
SK - Slovacchia (Repubblica Slovacca) 7
VE - Venezuela 7
YE - Yemen 7
AD - Andorra 6
AE - Emirati Arabi Uniti 6
AM - Armenia 6
AO - Angola 6
BS - Bahamas 6
BZ - Belize 6
CD - Congo 6
CM - Camerun 6
CY - Cipro 6
DJ - Gibuti 6
ET - Etiopia 6
KZ - Kazakistan 6
LA - Repubblica Popolare Democratica del Laos 6
MD - Moldavia 6
MU - Mauritius 6
MZ - Mozambico 6
NE - Niger 6
NZ - Nuova Zelanda 6
PA - Panama 6
PY - Paraguay 6
RS - Serbia 6
RW - Ruanda 6
SI - Slovenia 6
TN - Tunisia 6
UY - Uruguay 6
XK - ???statistics.table.value.countryCode.XK??? 6
Totale 6.036
Città #
Fairfield 609
Ashburn 357
Woodbridge 354
Houston 271
Chandler 261
Cambridge 234
Seattle 225
Singapore 223
Ann Arbor 202
Wilmington 199
Hong Kong 150
Beijing 73
Boardman 65
San Diego 62
Santa Clara 59
Munich 56
Princeton 48
Helsinki 43
Dong Ket 41
Medford 38
Des Moines 37
Jacksonville 37
Bytom 36
Roxbury 33
Padova 32
Nanjing 31
Los Angeles 29
New York 23
Chicago 18
Dearborn 18
Guangzhou 17
São Paulo 17
Milan 14
Ho Chi Minh City 13
Shenyang 13
Abidjan 12
Bishkek 12
Dublin 12
Ulan Bator 12
Falls Church 11
Hefei 11
Nanchang 11
Tokyo 11
Turku 11
Accra 10
Buffalo 10
Conakry 10
Redondo Beach 10
Riga 10
Bologna 9
Boston 9
Dushanbe 9
Nairobi 9
Reykjavik 9
Shanghai 9
Amman 8
Brooklyn 8
Cologno Monzese 8
Hanoi 8
Hebei 8
Managua 8
Praia 8
Tashkent 8
Cairo 7
Cotonou 7
Istanbul 7
London 7
Nouakchott 7
Ouagadougou 7
Paris 7
Phnom Penh 7
Zhengzhou 7
Bridgetown 6
Cagliari 6
Charlotte 6
Dar es Salaam 6
Frankfurt am Main 6
Gaborone 6
Kigali 6
Nassau 6
Niamey 6
Salt Lake City 6
Vienna 6
Vientiane 6
Zagreb 6
Addis Ababa 5
Amsterdam 5
Andorra la Vella 5
Ankara 5
Bangkok 5
Bucharest 5
Dallas 5
Djibouti 5
Falkenstein 5
Guatemala City 5
Jinan 5
Kinshasa 5
Luanda 5
Luxembourg 5
Noumea 5
Totale 4.425
Nome #
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 219
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 207
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 201
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 199
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 187
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 186
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 175
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 174
New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine? 174
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis 171
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 166
Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis. 165
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. 161
Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis 157
Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. 156
Why and how to measure renal function in patients with liver disease 154
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 154
Terlipressin given by continuous i.v. infusion versus i.v. boluses in the treatment of hepatorenal syndrome: A randomized controlled study. 149
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure 147
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome 146
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae 145
The liver: Another organ involved in Muir Torre syndrome? 145
Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? 144
Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. 143
Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis. 143
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. 140
Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be". 135
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 135
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis 127
Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir 124
Garlic extract prevents CCl4-induced liver fibrosis in rats: The role of tissue transglutaminase 118
The liver: Another organ involved in Muir Torre syndrome? 118
Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure 116
Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins 113
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis: results of a randomized controlled clinical trial 112
Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer 111
How to improve care in outpatients with cirrhosis and ascites: A new model of care coordination by consultant hepatologists. 110
Natural history of acute kidney disease in patients with cirrhosis 110
Bacterial infections in cirrhosis: epidemiology and prevalence of antibiotic resistence, a restrospective monocentric study 96
miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals 90
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: Clinical and virological outcomes 90
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis. 84
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge. 81
Hepatocarcinoma in chronic viral hepatitis: from epidemiological data, through new pathophysiological findings, up to new possible clinical tools 73
Follow-up post-HCV virological response to DAA in advanced chronic liver disease 56
Pathophysiological Differences and Differential Diagnosis of Autoimmune and Drug-Induced Hepatitis 16
Totale 6.323
Categoria #
all - tutte 21.396
article - articoli 20.663
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.059


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021592 0 0 0 41 26 43 34 54 73 151 96 74
2021/2022717 16 87 97 41 42 35 71 77 50 11 60 130
2022/2023509 96 61 13 66 64 85 1 30 62 2 28 1
2023/2024246 10 38 31 30 21 29 20 17 3 10 20 17
2024/20251.139 3 88 56 55 117 54 39 102 70 41 199 315
2025/20261.366 227 340 572 227 0 0 0 0 0 0 0 0
Totale 6.323